TTY Biopharm Company Limited (4105) Stock Price & Analysis
4105 Stock Chart & Stats
- Day’s Range
- TWD 77.10 - TWD 80.20
- 52-Week Range
- TWD 71.60 - TWD 87.00
- Previous Close
- TWD 80.20
- Volume
- N/A
- Average Volume (3M)
- 670.10K
- Market Cap
- TWD 19.69B
- Enterprise Value
- TWD 18.75B
- Total Cash (Recent Filing)
- TWD 2.94B
- Total Debt (Recent Filing)
- TWD 2.11B
- Price to Earnings (P/E)
- 12.2
- Beta
- 0.15
- Next Earnings
- Mar 17, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 26, 2026
- Dividend Yield
- 5.68%
4105 FAQ
What was TTY Biopharm Company Limited’s price range in the past 12 months?
What is TTY Biopharm Company Limited’s market cap?
When is TTY Biopharm Company Limited’s upcoming earnings report date?
How were TTY Biopharm Company Limited’s earnings last quarter?
Is TTY Biopharm Company Limited overvalued?
Does TTY Biopharm Company Limited pay dividends?
What is TTY Biopharm Company Limited’s EPS estimate?
How many shares outstanding does TTY Biopharm Company Limited have?
What happened to TTY Biopharm Company Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of TTY Biopharm Company Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
TTY Biopharm Company Limited
TTY Biopharm Company Limited, along with its associated entities, specializes in the creation and distribution of pharmaceutical and chemical products across Taiwan and global markets. Its operations are structured into several key divisions: Oncology, Intensive Care, Healthcare, Export & CDMO, and an "Other" Business Unit. For anti-cancer and supportive therapies, the company markets a range of oncology medications under prominent brand names such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre. Addressing infectious diseases and influenza, TTY Biopharm supplies anti-infection drugs including Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax. Furthermore, the firm offers various healthcare-related pharmaceuticals designed for the digestive system, osteoporosis, and metabolic conditions, marketed under brands like Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin. Beyond pharmaceuticals, the company is also involved in distributing functional foods, conducting international trade (import/export), and engaging in investment ventures. Established in 1960, TTY Biopharm maintains its principal office in Taipei, Taiwan.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ching-Lan Hou
- Employees
- 561
- Website
- www.tty.com.tw
- Address
- No.3-1, Park Street, Taipei, TP, 11503, TW
TTY Biopharm Company Limited (4105) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 5 | 9 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 5 | 0 | 7 |

